跳至主要内容
临床试验/CTRI/2024/09/074449
CTRI/2024/09/074449尚未招募不适用

Clinical evaluation of Dhanwantar Ghritam Matra Basti in Guda Arsha Haemorrhoids

Tejas Mishra1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年10月7日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To help regress the growth of hemorrhoids further into 3rd and 4th degree.

研究概览

简要总结

This is an open labelled clinical study to evaluate the effect of Dhanwantar Ghritam in Guda Arsha for the age group of 18 yeaars to 60 years for the duration of 28 days. 30 patients will be selected randomly irrespective of gender, race, religion, occupation.

The clinical study aims to provide better safe and effective management to the patient of Guda Arsha.

Total 30 patients will be registered for this study from the OPD/IPD of surgery department of quadra institute of ayurveda, roorkee.

Patients will be assessed on the basis of subjective and objective parameters before and after treatment. Detailed proforma will be prepared on the basis of Ayurvedic and allied sciences.

Observation of patients will be done before, during and after completion of trial.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient’s age ranging from 18 to 60 years.
  • 2.The patients having complaints of I and II degree internal Hemorrhoids will be taken for the study after screening.
  • 3.Patients willing to undergo trial and ready to give informed and written consent.

排除标准

  • 1.Patients below the age of 18 years and above the age of 60 years.
  • 2.Third degree prolapsed internal and external Haemorrhoids.
  • 3.Pregnancy.
  • 4.Congenital deformity.
  • 5.Known case of Carcinoma and Tuberculosis.
  • 6.Rectal prolapsed.
  • 7.Patients suffering from other systemic diseases such as HIV, known case of Hepatitis B, Ulcerative colitis, Crohn’s disease, Cirrhosis of liver and Carcinoma of rectum will be excluded from this study.
  • 8.Patient with uncontrolled DM and HTN.
  • 9.External thrombosed Haemorrhoids.
  • 10.The associated condition like Fistula-in-ano, Fissure-in-ano will be excluded from this study.

结局指标

主要结局

To help regress the growth of hemorrhoids further into 3rd and 4th degree.

时间窗: 28 days

次要结局

  • Provide a alternative and safe treatment for hemorrhoids.(18 months)

研究者

发起方
Tejas Mishra
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Tejas Mishra

Quadra Institute of Ayurveda and Hospital

研究点 (1)

Loading locations...

相似试验